Concepedia

Publication | Closed Access

Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis

192

Citations

9

References

2016

Year

Abstract

This retrospective case series provides Class IV evidence that bortezomib reduces antibody titers and improves the clinical course of patients with severe anti-NMDAR encephalitis.

References

YearCitations

Page 1